Researchers Use AI to Predict which COVID-19 Patients will Need a Ventilator to Breathe
The tool, developed through analysis of CT scans from nearly 900 COVID-19 patients diagnosed in 2020, was able to predict ventilator need with 84% accuracy.
Bittium Expands Its Minority Holdings in Remote Cardiology Service Companies in Europe
Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, and British ECG service provider, Technomed Limited, have today signed an agreement under which Bittium will purchase a 25 percent stake in Technomed's capital stock. The agreement will strengthen the partnership between the companies in the development of ECG technology that measure the electrical activity of the heart. Accenture HealthTech Innovation Challenge Names Eight Finalists
Accenture (NYSE: ACN) has named eight companies as finalists in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America's greatest health challenges.
Attracting more than 2,600 startup applicants in the past five years, the Accenture HealthTech Innovation Challenge supports finding innovative approaches and solutions to help create better healthcare access, experiences and ultimately outcomes for all people.
Clinerion Patent for Technology Underpinning Patient Network Explorer is Published
The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as well as any method for search of patient cohort care metrics across such a platform. This allows real-time search at each individual hospital across the entire network at once, returning aggregate metrics from the entire network. Bristol Myers Squibb Exercises Option to Develop Exscientia's AI-Designed, Immune-Modulating Drug Candidate
Exscientia, a clinical-stage, artificial intelligence (AI)-driven pharmatech company, today announced that Bristol Myers Squibb has elected to in-license an immune-modulating drug candidate created by Exscientia. Exscientia has two active collaborations with Bristol Myers Squibb, which together focus on multiple therapeutic areas, including oncology and immunology. Abbott Receives FDA Clearance for its Imaging Technology Using AI
Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. This innovative imaging software combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making and provide the best pathway for treatment. More eHealth News ...
Latest Business News
- X-on Launches Phonebar to Bring Telecoms to the Desktop
- South Tees Reachese-Prescribing Milestone in EPR Journey, with Alcidion and Better Meds
- Creating the Digital Health Workforce of the Future
- NHS Lanarkshire Launches Digital pre-Operative App to Transform Patient Care
- Roche Launches a Digital PCR System
Latest Research News
- Machine Learning Creates Opportunity for New Personalized Therapies
- Public Support Needed to Tackle Racial and other Biases in AI for Healthcare
- VR Reduced Need for Sedation During Hand Surgery
- Users Trust AI as Much as Humans for Flagging Problematic Content
- A Smartphone's Camera and Flash could Help People Measure Blood Oxygen Levels at Home
Latest Conferences News
- For Start-ups, MEDICA is the Gateway to the World - Programme Highlights: Two Competitions Boast an Exciting Finale
- Healthcare 5.0 Technologies at Healthcare Automation and Digitalization Congress 2022
- Social Aspects of Digitalization in the Modern Healthcare Industry at AUTOMA+ Healthcare 2022
- Using AI to Predict Bone Fractures in Cancer Patients
- Positive Conclusion to DMEA - Connecting Digital Health
Latest Jobs
- Full Professor of Ambient Assisted Living & Medical Assistance Systems
- (Senior) Project Lead Digital Transformation Consulting
- Global Product Manager - Digital Services for Healthcare
- Marcomms / PR Account / PR Account Manager - Healthcare & Technology
- ECG Data & AI Principal Scientist Director
- Head Marketing & Communications
- Amazon Launches New Postdoctoral Science Program